trial

Psychosis TMS Study

NCTId NCT05857137
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 20 (estimated)
Sponsored by Massachusetts General Hospital
Primary completion 2026-04-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2023-04-04
Primary completion
2026-04-15
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Active TMS

Sponsors

Massachusetts General HospitalLead Sponsor

Sites

1 total
Charlestown, United States

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2026-04-15
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Active TMS
drug
lead_sponsor
Massachusetts General Hospital
company
indication
Psychosis
indication
Cognitive Dysfunction
indication
Psychotic Disorders
indication